Short answer Ask for evidence-based hormone therapy under medical supervision — ideally FDA‑approved formulations of estradiol and, if you still have a uterus, micronized progesterone. That gives predictable dosing, known risks/benefits, and quality control. “Compounded BHRT” (custom-made hormones from compounding pharmacies) and hormone pellets are frequently promoted but have less oversight and weaker safety data. If you want a “bioidentical” product, choose FDA‑approved bioidentical estradiol and progesterone rather than compounded mixes. What those terms mean (brief) Traditional HRT: often refers to FDA‑approved estrogen and progestin products (examples: Premarin, Provera). Effective, well-studied. Bioidentical HRT (BHRT): means the hormone molecule matches human hormones (e.g., 17β‑estradiol, micronized progesterone). Some BHRT products are FDA‑approved (Estrace, Vivelle‑Dot, Climara, Prometrium). “Compounded BHRT” are custom mixtures made by compounding pharmacies — not FDA‑reviewed and variable quality. Which to ask for (practical recommendation) Start with FDA‑approved, evidence‑based therapy. Good, commonly used choices: Estradiol transdermal patch (Vivelle‑Dot, Climara, Alora) — transdermal route may have lower risk of venous thromboembolism than oral estrogen. Oral estradiol (Estrace) if oral route preferred. Micronized progesterone (Prometrium) if you have a uterus — protective for the endometrium and more “bioidentical” than synthetic progestins. For local vaginal symptoms, low‑dose vaginal estrogen (Vagifem, Estrace cream) is effective and low systemic exposure. If a clinician or you specifically want “bioidentical,” request FDA‑approved estradiol and micronized progesterone rather than compounded formulations. Avoid hormone pellets unless you’ve had a detailed discussion about risks/limited evidence and possible complications. Where to go / who to ask Primary options: Your primary care physician or your gynecologist — straightforward place to start. A menopause specialist or a dedicated menopause clinic for complex cases or if you want deeper consultation. Examples: Mayo Clinic Menopause Clinic, Cleveland Clinic Menopause Center, or academic medical centers in your region. Telehealth clinics specializing in menopause care can be convenient; examples include Plume (menopause-focused) and Tia (women’s health) — they provide clinician oversight and prescriptions. Verify they do appropriate screening and follow‑up. If a compounding pharmacy is needed (e.g., for a unique dose), use a PCAB‑accredited compounding pharmacy — search the PCAB directory. Examples of large compounding pharmacies that many clinicians use: Wedgewood Pharmacy, Fagron (but check local reputation and accreditation). What to discuss with the clinician Your symptoms, age, years since menopause, medical history (breast cancer, clotting, stroke, liver disease, cardiovascular disease), family history. Risks and benefits specific to your age/timing (starting HRT within ~10 years of menopause or under age 60 generally has a more favorable risk/benefit profile). Route: transdermal vs oral (transdermal often preferred if clot risk or high triglycerides). If you have a uterus, the need for progesterone to prevent endometrial cancer (Prometrium is a common bioidentical choice). Avoid saliva hormone testing for dosing — it’s unreliable. Baseline tests you’ll likely need: blood pressure, routine age-appropriate screening (mammogram as recommended), and follow-up plans. Suggested phrasing to bring to your appointment “I’m having [hot flashes/sleep problems/vaginal dryness]. I’d like to discuss hormone therapy. I’d prefer bioidentical estradiol and micronized progesterone (for example, transdermal estradiol patch and Prometrium) because I want an FDA‑approved, well‑studied option. Can we review my risks and the monitoring plan?” If considering compounded BHRT: “If you recommend compounded hormones, can you explain why an FDA‑approved option isn’t appropriate, and could we use a PCAB‑accredited pharmacy?” Safety notes HRT has benefits (relief of hot flashes, prevention of bone loss, improved quality of life) and risks (breast cancer, clotting, stroke — which vary by age, route, and type). Individualized assessment is essential. Compounded BHRT lacks the same regulatory oversight and consistent dosing; choose FDA‑approved products when possible. If you want, tell me: Your age, whether you still have a uterus, main symptoms, and any relevant medical history (clotting, breast cancer, heart disease). I can suggest a more tailored starting conversation and specific product choices.
Mentioned in position 10 of 14
Read full answer with sources →